Denosumab natural health news osteoporosis Prolia risk of monoclonal antibody drugs New Drug, New Risk Today it was announced that the FDA approved this new genetically engineered drug for osteoporosis. AMGEN is certainly looking forward to ... By apit nursing Thursday, June 3, 2010 Comment